|
Followers
|
14
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
199
|
|
Created
|
10/19/05
|
Type
|
Free
|
| Moderators | |||
http://www.npsp.com/
http://finance.yahoo.com/q/ks?s=NPSP
NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic small molecule drugs and recombinant proteins. Its products portfolio of approved drugs and product candidates are primarily used for the treatment of bone and mineral disorders, gastrointestinal disorders, and central nervous system disorders. The company's products for bone and mineral disorders include PREOS for the treatment of osteoporosis; Calcilytic Compounds, which are under Phase I clinical trail for the treatment of osteoporosis; and Cinacalcet HCl that completed Phase II clinical trial for the treatment of hypoparathyroidism. Its products for gastrointestinal disorders comprise Teduglutide, which is under Phase III clinical trail for the treatment of short bowel syndrome and under Phase II clinical trial for the treatment of Crohn's disease; and mGluRs antagonists, which are under preclinical trial for the treatment of gastroesophageal reflux disease. The company provides products for central nervous system disorders, such as mGluRs, which is under Phase I clinical trail for the treatment of psychiatric and neurologic disorders and pain; and glycine reuptake inhibitors that are in Phase I clinical trail for the treatment of schizophrenia and dementia. The company was founded in 1986 and is headquartered in Parsippany, New Jersey.
